Not applicableWithdrawnNCT02883972What this trial is testingChildhood Influenza Immunisation Invitation Trial in SchoolsWho this might be right forInfluenza, Human Public Health England
Early research (Phase 1)Study completedNCT01658800What this trial is testingStudy of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49Who this might be right forInfluenza VaxInnate Corporation 275
Early research (Phase 1)Looking for participantsNCT07645534What this trial is testingSafety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Who this might be right forInfluenzaAcute Respiratory Viral Infections Valenta Pharm JSC 36
Post-approval studies (Phase 4)Study completedNCT02215863What this trial is testingImmunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 YearsWho this might be right forInfluenzaStreptococcus Pneumoniae Korea University Guro Hospital 1,195
Post-approval studies (Phase 4)UnknownNCT02232945What this trial is testingBanlangen Granules Anti-seasonal Influenza StudyWho this might be right forInfluenza Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited 177
Not applicableStudy completedNCT01156701What this trial is testingProphylactic Efficacy of Relenza Against Influenza A and BWho this might be right forPulmonary Disease, Chronic ObstructiveBronchospasmInfluenza, Human+7 more GlaxoSmithKline 171,705
Large-scale testing (Phase 3)Study completedNCT01774032What this trial is testingH5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and OlderWho this might be right forInfluenza Alachua Government Services, Inc. 91
Not applicableStudy completedNCT02908893What this trial is testingPromoting Flu Vaccination Through a Mobile Wellness ProgramWho this might be right forNot Condition-specific Evidation Health 50,286
Testing effectiveness (Phase 2)Study completedNCT00133471What this trial is testingInactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Looking for participantsNCT06355232What this trial is testingCovid-19 and Influenza Oral Vaccine StudyWho this might be right forcovid19 InfectionInfluenza, Human Vaxine Pty Ltd 100
Not applicableUnknownNCT00798421What this trial is testingStudy to Evaluate Nosocomial Transmission of InfluenzaWho this might be right forInfluenza University Hospitals, Leicester 50
Large-scale testing (Phase 3)Study completedNCT01580033What this trial is testingPhase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineWho this might be right forMeningitisInfluenza Jiangsu Province Centers for Disease Control and Prevention 900
Large-scale testing (Phase 3)Ended earlyNCT05170009What this trial is testingBaloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With InfluenzaWho this might be right forInfluenza Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Study completedNCT00992433What this trial is testingH1N1 Vaccine at Two Dose Levels in HIV Positive AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 192
Not applicableStudy completedNCT05832333What this trial is testingPostmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 MonthsWho this might be right forInfluenza Sanofi 682
Not applicableStudy completedNCT07601126What this trial is testingRespiratory Pathogen Distribution During and After the COVID-19 PandemicWho this might be right forViral Respiratory Infection (e.g., Influenza)Bacterial Respiratory Infections Hisar Intercontinental Hospital 537
Large-scale testing (Phase 3)Study completedNCT03739112What this trial is testingEfficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the ElderlyWho this might be right forVirus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more Medicago 12,794
Early research (Phase 1)Study completedNCT01265914What this trial is testingEvaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A VaccineWho this might be right forInfluenza Immune Targeting Systems Ltd 49
Early research (Phase 1)Study completedNCT00112216What this trial is testingImmunotherapy of Melanoma PatientsWho this might be right forMelanoma Centre Hospitalier Universitaire Vaudois 9
Not applicableStudy completedNCT06646406What this trial is testingEvaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination RateWho this might be right forCOVID-19 ImmunisationInfluenza Vaccine Mayo Clinic 114,165